The canadian effort to prevent and control hypertension: Can other countries adopt canadian strategies?

Current Opinion in Cardiology

Volumn 25, Issue 4, 2010, Pages 366-372

  Campbell, Norm R C ^a   Sheldon, Tobe ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

Author keywords

clinical practice guidelines; epidemiology; high blood pressure; hypertension; public health

Indexed keywords

CANADA; CARDIOVASCULAR DISEASE; EDUCATION PROGRAM; HUMAN; HYPERTENSION; ORGANIZATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION;

CANADA; DIET, SODIUM-RESTRICTED; EVIDENCE-BASED MEDICINE; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; HYPERTENSION; INTERNATIONALITY; OUTCOME ASSESSMENT (HEALTH CARE); PUBLIC HEALTH; SOCIAL MARKETING; SODIUM, DIETARY;

EID: 77953808062     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32833a3632     Document Type: Review

References (46)

1. Lawes CMM, Vander Hoorn S, Law MR, et al. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006; 24:423-430. (Pubitemid 43261901)
2. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
3. Abboud H, Henrich WL. Stage IV chronic kidney disease. N Engl J Med 2010; 362:56-65.
4. Bild D, Teutsch SM. The control of hypertension in persons with diabetes: a public health approach. Public Health Rep 1987; 102:522-529.
5. Rodgers A, Vaughan P, Prentice T, et al. The World Health Report 2002. Geneva, Switzerland: World Health Organization; 2002.
6. Carter BL. Antihypertensive prescribing. Do we have reason to celebrate? Hypertension 2006; 48:816-817.
7. Joffres MR, Hamet P, MacLean DR, et al. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001; 14:1099-1105.
8. Lenfant C. Reflections on hypertension control rates. A message from the Director of the National Heart, Lung, and Blood Institute. Arch Intern Med 2002; 162:131-132.
9. Chockalingam A, Campbell N, Ruddy T, et al. Canadian national high blood pressure prevention and control strategy. Can J Cardiol 2000; 16:1087-1093.
10. Campbell NRC. Canada Chair in hypertension prevention and control: a pilot project. Can J Cardiol 2007; 23:557-560.
11. Campbell NRC, Drouin D, Feldman R. A brief history of Canadian hypertension recommendations. Hypertension Canada 2005; 82:1, 5, 7-8.
12. Feldman R, Campbell N, Larochelle P, et al. 1999 Canadian recommendations for the management of hypertension. CMAJ 1999; 161:S1-S17.
13. Zarnke KB, Campbell NRC, McAlister FA, Levine M. A novel process for updating recommendations for managing hypertension: rationale and methods. Can J Cardiol 2000; 16:1094-1102.
14. Campbell N, Burgess E, Taylor G, et al. Lifestyle changes to prevent and control hypertension: do they work? A summary of the Canadian Consensus Conference. CMAJ 1999; 160:1341-1343.
15. Davis D, Goldman J, Palda VA. Handbook on clinical practice guidelines. Ottawa, Ontario: Canadian Medical Association; 2007.
16. The AGREE Collaboration. Appraisal of guidelines for research and evaluation. London: St George's Hospital Medical School; 2001. pp. 1-24.
17. McAlister F. The Canadian Hypertension Education Program: a unique Canadian initiative. Can J Cardiol 2006; 22:559-564.
18. Drouin D, Campbell NR, Kaczorowski J. Implementation of recommendations on hypertension: the Canadian Hypertension Education Program. Can J Cardiol 2006; 22:595-598. (Pubitemid 44044215)
19. Padwal RS, Hemmelgarn BR, Khan NA, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension. Part 1: Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2009; 25:279-286.
20. Khan NA, Hemmelgarn B, Herman RJ, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension. Part 2: Therapy. Can J Cardiol 2009; 25:287-298.
21. Campbell NR, Onysko J. The Outcomes Research Task Force and the Canadian Hypertension Education Program. Can J Cardiol 2006; 22:556-558. (Pubitemid 44044210)
22. Hemmelgarn BR, Chen G, Walker R, et al. Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol 2008; 24:507-512.
23. Campbell NRC, McAlister FA, Brant R, et al. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens 2003; 21:1591-1597.
24. Onysko J, Maxwell C, Eliasziw M, et al. Large increases in hypertension diagnosis and treatment in canada following a healthcare professional education program. Hypertension 2006; 48:853-860.
25. Campbell NRC, Tu K, Brant R, et al. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 2006; 47:22-28.
26. Tu K, Campbell NRC, Durong-Hua M, McAlister FA. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002. Hypertension 2005; 45:1113-1118.
27. Leenen FH, Dumais J, McInnis NH, et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008; 178:1441-1449.
28. McAlister FA, Feldman RD, Wyard K, et al. The impact of the CHEP in its first decade. Eur Heart J 2009; 30:1434-1439.
29. Campbell NR, Brant R, Johansen H, et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009; 53:128-134.
30. Wilkins K, Campbell N, Joffres M, et al. Blood pressure in Canadian adults. Health Rep 2010; 21:1-10.
31. Padwal RJ, Hemmelgarn BR, Khan NA, et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension. Part 1: Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2008; 24:455-463.
32. Campbell NRC, Khan NA, Grover SA. Barriers and remaining questions on assessment of absolute cardiovascular risk as a starting point for interventions to reduce cardiovascular risk. J Hypertens 2006; 24:1683-1685.
33. Campbell N, Chen G. Canadian efforts to prevent and control hypertension. Can J Cardiol (in press).
34. Joffres M, Campbell NRC, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related healthcare costs in Canada. Can J Cardiol 2007; 23:437-443.
35. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens 2009; 27:1472-1477.
36. Geleijnse JM, Grobbee DE, Kok FJ. Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations. J Hum Hypertens 2005; 19:S1-S4.
37. World Health Organization. Reducing salt intake in populations: report of a WHO Forum and Technical Meeting 5-7 October, 2006 Paris, France. Geneva, Switzerland: World Health Organization; 2007. pp. 1-65.
38. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006; 49:59-75.
39. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23:363-384.
40. Asaria P, Chisholm D, Mathers C, et al. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007; 370:2044-2053.
41. Ordunez-Garcia P, Munoz JLB, Pedraza D, et al. Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens 2006; 24:845-849.
42. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52:818-827.
43. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control: continued disparities in adults: United States, 2005- 2006. NCHS Data Brief 2008; 1-8.
44. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension 2009; 53:480-486.
45. Falaschetti E, Campbell NR, Mohan S, Poulter N. Implementation of pay for performance policy in England. Hypertension 2009; 54:e5.
46. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-19.